HLA-B27 Antigen in Women With Ankylosing Spondylitis

June 1976 in “ JAMA ”

Peter M. Levitin, William W. Gough, John Staige Davis

Studysummary This study found that female patients with ankylosing spondylitis have a high association with the HLA-B27 antigen, similar to previous findings in males.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

Read the full study on doi.org →

PubMed
DOI

Discuss this study in the Community →

Similar research 5

Radiographic Findings of Shoulder Involvement in Ankylosing Spondylitis Reumatología Clínica (English Edition) · 2016
A Systematic Study on the Elevated Risk of Ankylosing Spondylitis in Adolescents Engaged in Intense Physical Exercise International Journal of Research in Orthopaedics · 2024
Association of Psoriasis and Psoriatic Arthritis with Human Leukocyte Antigen and Killer Cell Immunoglobulin-Like Receptor Gene Frequency: A Multiethnic Population Study Journal of The American Academy of Dermatology · 2009
Immunological And Some Biological Biomarkers Investigation In Patients With Systemic Lupus Erythematosus 2022
Specificity of Anti-SSB as a Diagnostic Marker for the Classification of Systemic Lupus Erythematosus Experimental and Therapeutic Medicine · 2013

Related Community Posts Join

6 / 1000+ results

community Having AGA as a girl makes me depressed

65 upvotes 7 months ago

A 20-year-old woman with androgenetic alopecia feels depressed about her hair loss, despite using topical minoxidil, spironolactone, and saw palmetto. Suggestions include trying oral minoxidil, higher doses of finasteride or dutasteride, and checking for vitamin deficiencies and heavy metal exposure.

community Spanish dermatologist suggests sulforaphane for AGA

in Research/Science 13 upvotes 2 years ago

A Spanish dermatologist suggests sulforaphane for androgenetic alopecia (AGA) due to its potential to remove DHT metabolites, though high dosages are needed. A topical formulation might be possible.

community Alopecia Areata Question

2 upvotes 5 years ago

A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.

community Has anyone done research on Absci's AI‑driven antibody platform? Seeking your thoughts!

4 upvotes 1 year ago

A user is interested in Absci's AI-driven antibody platform, ABS-201, for treating androgenetic alopecia, which shows promising preclinical results and potential for hair regrowth and pigmentation restoration. However, concerns are raised about the drug's development timeline and its advantages compared to existing treatments.

community EMA is re-examining Winlevi (clascoterone at lower concentration)

8 upvotes 1 year ago

Clascoterone in Winlevi, a topical AR antagonist, is being re-examined due to concerns about HPA axis suppression in adolescents, but it's unlikely to be banned for adult use in androgenetic alopecia (AGA). The European Medicines Agency recommended refusing Winlevi for acne vulgaris, but this may not affect Breezula's approval for AGA.

community What are the alternatives to spironolactone for AGA?

7 upvotes 1 year ago

The user experienced side effects from spironolactone and is seeking alternatives for androgenetic alopecia (AGA), considering saw palmetto but unsure of its effectiveness. They are also exploring the possibility of using topical spironolactone, despite availability challenges.